Bok Financial Private Wealth, Inc. Vertex Pharmaceuticals Inc Transaction History
Bok Financial Private Wealth, Inc.
- $1.58 Billion
- Q3 2025
A detailed history of Bok Financial Private Wealth, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bok Financial Private Wealth, Inc. holds 1,279 shares of VRTX stock, worth $555,111. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,279
Previous 1,258
1.67%
Holding current value
$555,111
Previous $560,000
10.71%
% of portfolio
0.03%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...